谷歌Chrome浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

198 3-month ivacaftor (Kalydeco™) treatment resulted in weight gain, decreased resting energy expenditure and gut inflammation, and increased pulmonary function, muscle mass and strength, and growth status

V. Stallings,C. McAnlis,J. Samuel, E. Karalunas, A. Hyczko,C. Bertolaso, N. Sainath,J. Schall

Journal of Cystic Fibrosis（2016）

引用 1|浏览5
暂无评分
关键词
Infant Health
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要